Skip to main content
. 2022 Nov 8;11(11):2211. doi: 10.3390/antiox11112211

Table 6.

Summary of the pilot study data and results. * Based on the difference in SARS gene initial CT value and 34 (threshold for a negative test result). Abbreviations: CT: cycle threshold; M: male; F: female; yrs: years; no.: number; PCR: polymerase chain reaction; BMI: body mass index.

Case No. (Subject) Date Age (yrs) M/F Co-Morbidity Days after Onset Initial CT Value Viral Load Reduction Factor * Days to Negative
PCR
1 26 June 2021 61 F BMI 31.1
Recurrent
Bronchitis
8 16.34/17.19 207,000 7
2 6 July 2021 55 M BMI 34
Hypertension
Smoker
5 20.17/22.12 - Clinically recovered within 12 h (Refused repeat test)
3 6 July 2021 40 M BMI 31.7 5 18.99/20.43 32,768 4
4 10 July 2021 38 F BMI 31.3 3 11.96/15.97 4,194,304 4
5 17 July 2021 42 M BMI 32.5 5 18.14/19.24 - Did not complete treatment protocol. Hospitalized 3 days after discontinuing treatment
6 18 July 2021 31 F BMI 27.6
Pregnant 8 months gestation
5 15.21/16.62 450,000 7
7 21 July 2021 47 F BMI 29.2 2 26.96/29.04 128 4
8 28 July 2021 38 M BMI 32.5 3 6.05/9.41 259,000,000 8 (Follow up
testing was
delayed)